The table below shows Moderna, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$630.00M
-$1.04B
-$989.00M
-$1.23B
$2.76B
$2.97B
Capital expenditure
$62.00M
$117.00M
$196.00M
$113.00M
$132.00M
$35.00M
Investing cash flow
-$76.00M
$730.00M
$118.00M
$2.01B
-$3.92B
-$180.00M
Dividends paid
-
-
-
-
MRNA operating cash flow (10-K history)
Moderna, Inc. reported operating cash flow of -$1.87B for fiscal year 2025. That is up 37.6% from -$3.00B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $66.73M (FY 2016) to -$1.87B. Figures come from the company's audited annual reports as filed with the SEC.
